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Summary
Background: Though the physiological roles of adipokines in metabolism, insulin
resistance and satiety are clear, literature regarding associations between cord blood
adipokine levels and childhood adiposity is equivocal.
Objectives: To determine whether cord blood levels of leptin and adiponectin are
associated with adiposity in children 2 to 5 years of age, and whether such associa-
tions are modified by sex.
Methods: Leptin and adiponectin levels were measured in cord blood and anthropo-
metric measures were completed on 550 children enrolled in the Maternal–Infant
Research on Environmental Chemicals Child Development Plus study (MIREC-CD
Plus). We used multivariable linear and Poisson regression models to determine asso-
ciations between cord blood adipokine levels and child body mass index (BMI), tri-
ceps and subscapular skinfold thickness and risk of overweight/obesity and to assess
effect modification by child sex.
Results: Cord blood adiponectin was significantly associated with modest increases
in BMI and the sum of triceps and subscapular skinfold z-scores in boys but not girls.
A doubling of adiponectin levels was associated with a 30% increased risk of
overweight/obesity in boys (RR = 1.30; 95% CI: 1.02, 1.64). Leptin was not associ-
ated with anthropometric measures in either sex.
Conclusions: The observed associations between adiponectin and adiposity in boys
were statistically significant, of moderate magnitude, and underscore the value of
considering sex-specific patterns.
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1 | INTRODUCTION
In recent decades, childhood obesity has increased dramatically in
both developed and developing countries.1 Childhood obesity tracks
into adulthood and is associated with an increased risk of developing
chronic conditions such as cardiovascular disease and metabolic syn-
drome, resulting in significant public health and economic burdens.2,3
While caloric imbalance remains the primary mechanism behind the
obesity epidemic, recent studies have explored whether childhood
obesity has etiological roots in fetal development.4,5 Umbilical cord
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blood adipokines, particularly leptin and adiponectin, have been
hypothesized as potential biomarkers of early life adiposity.6,7 Leptin,
an adipocyte-derived protein, is an established marker for fetal adi-
posity.7,8 Studies have shown that cord blood leptin levels positively
correlate with fetal adiposity at birth.6,7,9 In addition, leptin may play a
role in later life obesity by acting on hypothalamic receptors to regu-
late energy homeostasis and satiety.10,11 Individuals with obesity may
develop leptin resistance and subsequently lose the ability to regulate
satiety and gain weight.12 Adiponectin is exclusively produced by adi-
pocytes and plays an important role in the regulation of insulin sensi-
tivity in adults. In contrast to leptin, adiponectin is found in lower
circulating levels among adults with obesity.13 At birth, adiponectin
may promote fat deposition,14,15 but potential obesity programming
mechanisms are not well established.
Recent studies have explored associations between cord blood
adipokines and child adiposity, but findings are largely conflicting and
have primarily evaluated associations in the overall study population
rather than among boys and girls separately. Though cord blood leptin
has been inversely associated with adiposity16-19 and accelerated
weight gain during childhood,19-22 null18,21 and positive23,24 associa-
tions between leptin and child growth have also been reported. Simi-
larly, there is lack of consensus regarding the role of adiponectin in
early childhood growth or adiposity with null,19,25,26 inverse,26 and
positive19,25,26 associations being reported depending on the age of
child, specific anthropometric measure and choice of confounders.
Our primary objective was to quantify associations between cord
blood levels of leptin and adiponectin and child adiposity in a popula-
tion of Canadian preschool children. Our secondary objective was to
examine potential effect modification by child sex, in light of the lack
of attention devoted to potential sex-specific effects of cord blood
adipokines on child growth in the literature. Girls are known to have
higher cord blood leptin levels and lower average birthweight27,28
than males. It is, therefore, possible that the potential effects of cord
blood adipokine levels on childhood growth may differ by child sex.
2 | METHODS
2.1 | Study population
Our study population included children enrolled in the Maternal–
Infant Research on Environmental Chemicals Child Development Plus
(MIREC-CD Plus) study. The study profile and detailed eligibility
criteria of the original MIREC cohort have been previously reported.29
Women were recruited during their first trimester of pregnancy from
10 Canadian sites between 2008 and 2011. Leptin and adiponectin
levels were measured in 1363 umbilical cord blood samples.30
MIREC-CD Plus, a follow-up study, recruited 784 MIREC families with
children 2 to 5 years of age from six participating sites (Vancouver,
Toronto, Kingston, Montreal and Halifax). The children had both neu-
robehavioral and anthropometric follow-up assessments. Participants
were eligible for inclusion in this analysis if the mother delivered a live
term, singleton infant without a congenital anomaly, had an analyzed
cord blood sample and participated in the MIREC-CD Plus Study. We
excluded children born prior to 37 weeks gestation as, consistent with
previous research,31 we observed that cord blood leptin and
adiponectin levels were lower in this group.
2.2 | Exposure: cord blood adipokines
Cord blood samples were collected following delivery. Leptin and total
adiponectin concentrations were measured using assay kits from
Meso Scale Discovery (MSD) (Rockville, MD, USA) at Mt. Sinai Labo-
ratory (Toronto, ON, Canada). The inter- and intra-assay coefficient of
variations were 12% and 9%, respectively, for leptin and 8% and 9%,
respectively, for adiponectin. All samples were above the limits of
detection (leptin: 0.04 ng/mL, adiponectin: 0.005 μg/mL).
2.3 | Outcome: child anthropometry variables
Our primary outcome measures were body mass index (BMI), skinfold
(SF) sum and ratio z-scores. The sum of subscapular (SSF) and triceps
(TSF) skinfold thicknesses is a feasible and reliable measure of esti-
mating total adiposity, whereas the ratio of SSF to TSF provides an
estimate of the relative distribution of adiposity.32,33 Both of the com-
posite measures have been used in previous studies of the association
between adipokines and child adiposity.17,19,22
At the MIREC-CD Plus biomonitoring home visit, trained research
personnel measured the child's weight with a calibrated scale (Seca
model 874 [Seca Corporation, Hanover, MD, USA]), standing height
using a calibrated stadiometer (Seca model 217 [Seca Corporation,
Hanover, MD, USA]) and SSF and TSF using a Lange skinfold caliper
(Cambridge Scientific Instruments, Cambridge, MA, USA). All measure-
ments were completed in duplicate and the average of both measured
values was used. If the two measures differed by a pre-determined
value (weight > 0.1 kg, height > 0.5 cm, SSF > 2 mm, TSF > 2 mm), a
third measurement was performed. A third weight, height, TSF and
SSF measurement was performed in 24%, 10%, 3% and less than 1%
of individuals, respectively. Age- and sex-specific z-scores for BMI
were calculated for each child based on WHO Child Growth Stan-
dards.34 Due to the lack of reference standards for skinfold sum and
ratio, we developed age- and sex-specific percentile curves within the
study sample for these two measures using the LMS method35; the
raw values from the percentiles were then converted into z-scores.
Individuals with values of z-scores that were greater than five or
less than negative five for any of the outcomes measures were
removed from the analysis as these values are considered biologically
implausible.36
2.4 | Covariates
Trained research staff administered questionnaires on
sociodemographic characteristics, lifestyle habits and medical and
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reproductive history during the first and third trimesters.29 Maternal
height and weight were measured in each trimester; pre-pregnancy
weight was self-reported by the mothers and used to calculate pre-
pregnancy BMI. Paternal height and weight were measured at the
MIREC-CD Plus home visit or reported by the mother if the father
was not in attendance. Birthweight and gestational age at delivery
data were extracted from medical charts. Each child's birthweight for
gestational age z-score was calculated based on a Canadian
population-based standard.37
2.5 | Statistical analysis
Sample characteristics are presented as counts and percentages, the
median (interquartile range [IQR]) of leptin and adiponectin levels
were calculated for each stratum, and BMI, SF sum and SF ratio z-
scores were summarized using mean and standard deviation (SD). We
quantified the association of cord blood leptin and adiponectin with
child anthropometric measures (BMI z-score, SF sum z-score and SF
ratio z-score) using separate linear regression models. Due to the
skewed distributions of both adipokines, we log2-transformed leptin
and adiponectin prior to modelling. Using base 2 log transformation
allows easy interpretation of regression estimates as a one unit
increase in the transformed variable is equivalent to a doubling of the
raw variable. We also evaluated the association between cord blood
adipokines and risk of having overweight or obesity based on a BMI z-
score greater than one using Poisson regression with robust standard
errors.38 Model fit was assessed with regression diagnostics.
Confounders were identified using a directed acyclic graph based
on previous literature of determinants of cord blood adipokines and
child anthropometric measures and included maternal age,17 pre-
pregnancy BMI,17,19,30,39,40 gestational weight gain17,40 and paternal
BMI.17,39 Due to the high correlation between cord blood leptin and
birthweight,7,19 we attempted to remove the effect of birthweight on
associations between cord blood adipokines and child growth by addi-
tionally adjusting the regression models for birthweight for gestational
age z-score. We also tested for interactions and stratified the analyses
by child sex. To account for missingness in the covariates, we per-
formed multiple imputation with chained equations (m = 30, 30
iterations).41
This study received ethics approval from the Research Ethics
Board at the IWK Health Centre (Halifax, NS, Canada), the Research
Ethics Board at Health Canada and the Research Ethics committee at
Ste. Justine's Hospital (Montreal, QC, Canada). All mothers provided
written consent for themselves and their infants. All analyses were
performed using SAS version 9.3 (SAS Institute Inc., Cary, NC) and R
version 3.5.2.42
3 | RESULTS
Out of the 579 children in MIREC-CD Plus who had cord blood
adipokines and anthropometric follow-up assessments, 550 mother–
child pairs were included in the present analysis. Of these, 541 chil-
dren had complete BMI z-score data, 500 had complete SF sum data
and 498 had complete SF ratio data. In addition to exclusions due to
plurality and prematurity, three children were removed due to either a
BMI z-scores greater than 5 or a SF ratio z-scores greater than 5.
Mothers of children in this analysis were primarily over 30 years of
age at time of delivery, had a normal pre-pregnancy BMI and were of
moderate to high socioeconomic status, Caucasians and non-smokers
(Table 1). The mean age of children at the time of the MIREC-CD Plus
follow-up visit was 42 months (range: 22–75 months). Mean (SD) of
BMI, SF sum and SF ratio z-scores were 0.49 (0.88), 0.05 (0.99) and
0.01 (1.07). Twenty-five percent of children were classified as being
overweight or having obesity. Median cord blood leptin and
adiponectin concentrations were 11 ng/mL (IQR 5.3, 23) and
16 μg/mL (IQR 10, 23), respectively. Median leptin concentrations
were 15 (IQR 7.3, 28) among girls and 8.6 among boys (IQR 4.3, 18).
Median adiponectin concentrations were similar between boys (16,
IQR 9.7, 23) and girls (16, IQR 10, 24). Cord blood adipokines levels
by sample characteristics are shown in Table 1.
We observed no statistically significant association between
cord blood adipokines and the anthropometric measures in the
overall sample (Table 2). In the sex-stratified analyses (Table 3), lep-
tin was weakly inversely associated with BMI z-score among girls in
the model adjusted for birthweight for gestational age (model 3). No
statistically significant association was observed between leptin and
the skinfold measures in either boys or girls. We observed no effect
modification between leptin and sex for any of the outcomes (p
value for heterogeneity >0.1 for each outcome). Adiponectin was
positively associated with both BMI z-score and SF sum z-score in
boys but not girls. A doubling of adiponectin was associated with a
0.1 (95% CI 0.01, 0.2) and 0.1 (95% CI 0.01, 0.3) increase in BMI z-
scores and SSF + TSF z-scores, respectively. We observed effect
modification between adiponectin and sex in the BMI (p = 0.04) and
SSF + TSF (p = 0.03) models, but not in the SSF/TSF model
(p = 0.68).
We observed no association between either adipokine and
overweight/obesity in the overall sample. (Table 4). When stratified
by sex and adjusted for the base covariates (model 2), adiponectin
was positively associated with overweight/obesity in boys (risk
ratio = 1.30, 95% CI 1.02, 1.64) but not in girls. Results were similar in
the model adjusted for birthweight for gestational age z-score (model
3). No associations were observed for leptin with overweight/obesity
in either boys or girls.
4 | DISCUSSION
In this cohort of Canadian preschool children, we observed sex-
specific differences in the associations between cord blood adipokines
and child growth. Specifically, cord blood adiponectin levels were pos-
itively associated with modest increases in BMI z-scores and the sum
of skinfolds in boys but not girls. A doubling of cord blood adiponectin
levels was associated with a 30% increased risk of overweight and
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obesity in boys. No consistent patterns of association were observed
in girls. Similarly, analyses of the overall sample revealed no statisti-
cally significant association between cord blood adipokine levels and
childhood growth.
Though the etiological role of cord blood leptin in child growth
has been evaluated in several longitudinal birth cohort
studies,16,19,22,24,25 only two evaluated effect modification by sex.16,22
The Project Viva Study, a cohort that includes approximately 500
TABLE 1 Maternal cord blood leptin and adiponectin concentrations by sociodemographic and pregnancy characteristics (n = 550)
Characteristic Number Percent (%)
Leptin [ng/mL] Adiponectin [μg/mL]
Median (IQR) Median (IQR)
Maternal age at enrollment (years)
≤ 24 19 (3.5) 13 (5.7, 22) 21 (9.2, 27)
25–29 122 (22) 12 (6.8, 23) 16 (9.7, 23)
30–34 208 (38) 11 (5.5, 23) 16 (10, 23)
≥ 35 201 (37) 10 (4.8, 21) 15 (10, 23)
Pre-pregnancy BMI (kg/m2)
< 25 341 (63) 7.3 (1.4, 34) 15 (10, 23)
25–29.9 112 (21) 10 (4.8, 21) 15 (9.5, 23)
≥ 30 86 (16) 12 (6.6, 25) 17 (11, 22)
Parity
Nulliparous 231 (42) 12 (5.4, 25) 16 (10, 24)
Parous 319 (58) 11 (5.2, 21) 16 (10, 22)
Education
High school or less 33 (6.0) 10 (4.7, 17) 16 (10, 21)
College, trade school 137 (25) 11 (5.1, 18) 15 (8.3, 23)
Undergraduate degree 238 (43) 12 (5.7, 23) 16 (11, 23)
Graduate degree 140 (26) 10 (4.9, 25) 16 (11, 24)
Household income (CAD)
≤ $50,000 80 (15) 12 (5.6, 22) 15 (9.2, 23)
$50,001–$100,000 236 (43) 12 (5.7, 24) 16 (10, 24)
≥ $100,001 234 (43) 11 (4.9, 21) 16 (9.8, 23)
Ethnicity
Caucasian 465 (85) 11 (5.2, 23) 16 (10, 23)
Not Caucasian 85 (15) 11 (6.6, 22) 16 (11, 21)
Maternal smoking
Never/before pregnancy 503 (91) 11 (5.3, 23) 16 (10, 23)
Quit when pregnant 33 (6.0) 12 (4.6, 20) 13 (8.0, 21)
Current 14 (2.6) 14 (6.7, 23) 19 (12, 33)
Gestational weight gain (IOM)
Inadequate 86 (16) 11 (4.5, 22) 13 (8.2, 21)
Adequate 165 (32) 9.9 (4.7, 21) 17 (11, 23)
Excessive 272 (52) 12 (5.8, 25) 16 (11, 24)
Paternal BMI (kg/m2)
< 25 155 (29) 9.9 (4.8, 20) 16 (11, 23)
25–29.9 254 (47) 11 (5.3, 24) 15 (8.8, 23)
≥ 30 128 (24) 13 (6.5, 23) 17 (11, 24)
Child sex
Boys 287 (52) 8.6 (4.3, 18) 16 (10, 23)
Girls 263 (48) 15 (7.3, 28) 15 (10, 23)
Note. Missing: Pre-pregnancy BMI 11, Education 2, Income 16, GWG 27, Paternal BMI 13.
Abbreviations: BMI, body mass index; CAD, Canadian Dollar; IOM, Institute of Medicine; IQR, interquartile range.
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mother–child pairs recruited from Massachusetts, USA, examined
cord blood leptin and child growth at age 3 years. Consistent with our
findings, the authors found no association between maternal leptin
and BMI z-score at age 3; sex-specific results were not presented.16
The Rhea study, a cohort of Greek mother–child pairs (n = 578),
reported an inverse association between cord blood leptin levels and
BMI that was slightly stronger in boys than girls at age 4.22 These
findings contrast our observed lack of statistically significant interac-
tions in the leptin models, but the use of raw BMI rather than BMI z-
score as the primary outcome measure in the Rhea study precludes
direct comparison with our results.
To our knowledge, no study has evaluated sex-specific results of
the association between cord blood adiponectin and child growth.
This finding is interesting considering that, unlike cord blood leptin
TABLE 2 Linear regression estimates of log2 cord blood leptin and adiponectin and child anthropometric measure z-scores
Model
BMI SSF + TSF SSF/TSF
β (95% CI) β (95% CI) β (95% CI)
Leptin [ng/mL]
M1 0.04 (−0.006, 0.08) 0.02 (−0.03, 0.08) 0.004 (−0.05, 0.06)
M2 0.02 (−0.02, 0.06) 0.01 (−0.04, 0.06) 0.01 (−0.05, 0.07)
M3 −0.04 (−0.09, 0.002) 0.0004 (−0.06, 0.06) 0.007 (−0.06, 0.07)
Adiponectin [μg/mL]
M1 0.08 (0.007, 0.1) 0.05 (−0.04, 0.1) 0.1 (−0.02, 0.2)
M2 0.07 (−0.03, 0.1) 0.03 (−0.05, 0.1) 0.1 (−0.03, 0.2)
M3 0.03 (−0.03, 0.1) 0.03 (−0.06, 0.1) 0.09 (−0.04, 0.2)
Note. M1: Unadjusted; M2: Adjusted for pre-pregnancy BMI, paternal BMI, maternal age, gestational weight gain; M3: Model 2 plus birthweight for
gestational age z-score.
Abbreviations: BMI, body mass index; CI, confidence interval; SSF, subscapular skinfold; TSF, triceps skinfold.
TABLE 3 Linear regression estimates of log2 cord blood leptin and adiponectin and child anthropometric measure z-scores among boys and
girls
Model
BMI SSF + TSF SSF/TSF
β (95% CI) β (95% CI) β (95% CI)
BOYS
Leptin (ng/mL)
M1 0.05 (−0.01, 0.1) 0.02 (−0.06, 0.09) 0.01 (−0.07, 0.09)
M2 0.04 (−0.02, 0.1) 0.007 (−0.07, 0.09) 0.01 (−0.07, 0.09)
M3 −0.02 (−0.08, 0.05) 0.001 (−0.09, 0.09) −0.002 (−0.09, 0.09)
Adiponectin (μg/mL)
M1 0.2 (0.07, 0.3)* 0.1 (0.02, 0.3)* 0.05 (−0.08, 0.2)
M2 0.2 (0.05, 0.3)* 0.1 (0.01, 0.3)* 0.05 (−0.08, 0.2)
M3 0.1 (0.01, 0.2)* 0.1 (0.01, 0.3)* 0.05 (−0.09, 0.2)
GIRLS
Leptin (ng/mL)
M1 0.04 (−0.02, 0.1) 0.03 (−0.05, 0.1) −0.004 (−0.09, 0.08)
M2 0.001 (−0.07, 0.07) 0.01 (−0.07, 0.09) 0.004 (−0.09, 0.1)
M3 −0.07 (−0.1, −0.001)* 0.001 (−0.08, 0.09) 0.003 (−0.09, 0.1)
Adiponectin (μg/mL)
M1 −0.002 (−0.1, 0.09) −0.002 (−0.1, 0.09) 0.04 (−0.08, 0.2)
M2 −0.02 (−0.1, 0.07) −0.04 (−0.1, 0.08) 0.04 (−0.09, 0.2)
M3 −0.05 (−0.1, 0.04) −0.04 (−0.1, 0.07) 0.04 (−0.09, 0.2)
Note. M1: Unadjusted; M2: Adjusted for pre-pregnancy BMI, paternal BMI, maternal age, gestational weight gain M3: Model 2 plus birthweight for
gestational age z-score.
Abbreviations: BMI, body mass index; CI, confidence interval; SSF, subscapular skinfold; TSF, triceps skinfold.
*p < 0.05.
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where sex-specific differences are apparent at birth, adiponectin
levels are relatively similar in both sexes throughout childhood, yet
may diverge in adolescence. A study of Mexican-American children
reported no differences in adiponectin levels between boys and girls
from birth to age 9.43 In non-stratified analyses, cord blood
adiponectin has been positively associated with the SSF/TSF ratio at
age 3 in Project Viva,19 with body composition at age 3 in twins23 and
with fat mass at 2 weeks but not 3 months in offspring of African
American women.26 In addition, authors of a study in Oklahoma
reported that cord blood levels of high molecular weight adiponectin
were positively associated with three measures of adiposity (SSF,
body weight and percent fat) in male and female infants at 1 month of
age.44 Null findings between adiponectin and multiple anthropometric
measures (eg, BMI z-score and fat mass) have also been observed at
age 924 and age 5.25 Our finding of stronger associations in males
raises the question of whether the population-level effects observed
in these studies would have been strengthened in the subset of male
study participants.
Several physiological mechanisms may underlie the observed dif-
ferences by sex in the adiponectin-growth associations. Lower
oestrogen concentrations in males may heighten male susceptibility to
the adverse effects of maternal adiposity and fetal hormone concen-
trations. The placenta of male fetuses may be more susceptible to
environmental stressors and obesity than the female placenta.45 It is
possible that these oestrogen- and placental-driven mechanisms
translate into sex differences in the adiponectin but not leptin models.
Males and females may respond to adipokine hormone differently due
to underlying differences in fat distribution with males being charac-
terized by a greater distribution of visceral fat than subcutaneous fat.
For example, the brains of male rats have been shown to be more sen-
sitive to insulin than female rats.46 We raise the question of whether
adiponectin, as an indicator of insulin resistance, may similarly evoke
different responses in males compared to females. Cord blood
adiponectin has been shown to be positively associated with reduced
beta cell function at age 1 in a pregnancy cohort in Montreal,
Canada47; sex-specific differences were not reported. On the other
hand, because fetal fat distribution is similar between sexes,48 it is
possible that sex-specific hormonal responses may not be apparent
until later in life.
Adiponectin levels are highest at birth and decrease with age. The
positive correlation between adiponectin and birthweight transitions
to a negative correlation between adiponectin and both adult weight
and insulin resistance.14 Children with higher rates of weight gain and
BMI during infancy tend to have lower adiponectin levels in early ado-
lescence.43 There is limited evidence that low adiponectin levels in
early adolescence are linked to an increased risk of metabolic syn-
drome.49 In light of these temporal changes and the complexity of
adiponectin's physiological effects, it is not possible to infer long-term
clinical implications from the present study. Further follow-up of chil-
dren in the MIREC study will also enable analyses of the trajectory of
adiponectin to determine if boys with high cord blood levels tend to
have lower levels in adolescence.
Our findings of largely null associations with leptin in the full sam-
ple are relatively consistent with previous research demonstrating null
or small effects. Studies that have found inverse associations between
leptin and early childhood growth tended to observe that inverse
associations are present in childhood prior to adolescence – during
the time of leptin sensitivity – and are attenuated with increasing age
as tolerance to the effects of leptin on metabolism and satiety are
developed.17,24
The strengths of this study are the prospective national-level data
and ability to control for key confounders. We were limited by a rela-
tively small sample size and lack of uniform follow-up time; we
attempted to correct for the latter issue using age and sex specific z-
scores. Moreover, given the unique composition of the MIREC cohort,
our findings may not be generalizable to studies of differing socioeco-
nomic composition or ethnicity.
In conclusion, we observed that cord blood adiponectin was posi-
tively associated with modest differences in child adiposity in boys
but not girls. These findings underscore the importance of evaluating
potential effect modification by sex and motivate further investigation
regarding the temporal patterns of adiponectin, child growth and






M1 1.05 (0.965, 1.15) 1.08 (0.958, 1.22) 1.05 (0.908, 1.21)
M2 1.02 (0.938, 1.12) 1.07 (0.945, 1.22) 0.972 (0.847, 1.11)
M3 0.949 (0.864, 1.04) 1.02 (0.887, 1.17) 0.879 (0.762, 1.02)
Adiponectin [μg/mL]
M1 1.15 (0.977, 1.35) 1.35 (1.09, 1.68) * 0.985 (0.804, 1.21)
M2 1.13 (0.962, 1.33) 1.30 (1.02, 1.64) * 0.963 (0.790, 1.17)
M3 1.09 (0.932, 1.28) 1.26 (1.02, 1.57) * 0.929 (0.767, 1.13)
Note. BMI z-score ≥ 1. M1: Unadjusted; M2: Adjusted for pre-pregnancy BMI, smoking, paternal BMI, maternal age, gestational weight gain; M3: M2 plus
birthweight for gestational age z-score.
Abbreviations: BMI, body mass index; CI, confidence interval; RR, risk ratio.
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development of adverse body composition and cardiometabolic
profiles.
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